Premium
Etretinate in the Treatment of Disseminated Porokeratosis of Mibelli
Author(s) -
HachamZadeh Shoshana,
Holubar Karl
Publication year - 1985
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4362.1985.tb05459.x
Subject(s) - etretinate , medicine , porokeratosis , dermatology , surgery , psoriasis
ABSTRACT: A 30‐year‐old man with disseminated porokeratosis of Mibelli (DPKM) was treated with oral etretinate. The dose ranged between 75 mg/day and 50 mg/day for 21 weeks. An improvement of the lisions was observed especially of very painful verrucous plaques of the left shin. No serious side effects was seen. The patient, who had been incapacitated, is now able to work. The benefit of long‐term therapy of etretinate should ne considered against its side effects.